Related Experiment Video
Updated: May 10, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Pregabalin attenuates excitotoxicity in diabetes
Chin-Wei Huang1, Ming-Chi Lai, Juei-Tang Cheng
1Department of Neurology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. huangcw@mail.ncku.edu.tw
Plos One
|June 21, 2013
Summary
The antiepileptic drug pregabalin (PGB) shows potential in preventing seizures and brain damage in diabetic rats. PGB protects neurons by opening ATP-sensitive potassium channels (KATP), suggesting a role in managing epilepsy with diabetes.
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus can worsen seizure severity and associated brain damage.
- Understanding the neuroprotective effects of antiepileptic drugs in diabetes is crucial for comorbid conditions.
Purpose of the Study:
- To investigate if pregabalin (PGB) protects against seizures and excitotoxicity in a rat model of diabetes.
- To elucidate the mechanism underlying PGB's potential neuroprotective effects in the context of diabetes.
Main Methods:
- Induction of diabetes using streptozotocin (STZ) in Sprague-Dawley rats.
- Administration of PGB or vehicle followed by pilocarpine-induced seizures.
- Evaluation of spontaneous recurrent seizures (SRS), neuronal loss, and mossy fiber sprouting.
- Patch clamp recordings and RNA interference to study PGB's effect on ATP-sensitive potassium channels (KATP).
Main Results:
- PGB treatment reduced seizure severity, acute neuronal loss, and chronic mossy fiber sprouting in diabetic rats.
- PGB's effects on neuronal excitability were linked to the modulation of KATP channels.
- PGB counteracted the KATP-closing effect of high-dose ATP, indicating a protective mechanism.
Conclusions:
- Pregabalin (PGB) demonstrates antiepileptogenic potential in diabetes by protecting against seizures and excitotoxicity.
- PGB's mechanism involves opening ATP-sensitive potassium channels (KATP), offering neuroprotection.
- Findings support PGB as a potential therapeutic agent for epilepsy in patients with diabetes.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...